| A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC) (NCT04965090) | Memorial Sloan Kettering Cancer Center | 2021-09-30 |
| Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer (NCT06525246) | Ono Pharmaceutical Co., Ltd. | 2021-08-06 |
| A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) (NCT04623775) | Bristol-Myers Squibb | 2021-02-17 |
| Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab (NCT02919449) | Vyriad, Inc. | 2017-08-03 |
| Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer (NCT02845856) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer (NCT02655913) | Clifford Hospital, Guangzhou, China | 2015-12-01 |
| Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery (NCT02262325) | Ohio State University Comprehensive Cancer Center | 2015-06-08 |
| Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer (NCT02132884) | Fox Chase Cancer Center | 2015-03-01 |
| Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers (NCT02243748) | City of Hope Medical Center | 2015-02-01 |
| Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung Cancer (NCT02250378) | University of Southern California | 2014-10-01 |
| S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib (NCT02134912) | SWOG Cancer Research Network | 2014-08-01 |
| Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer (NCT02178163) | Barbara Ann Karmanos Cancer Institute | 2014-08-01 |
| Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer (NCT02059889) | Virginia Commonwealth University | 2014-07-01 |
| Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer (NCT02145078) | Barbara Ann Karmanos Cancer Institute | 2014-06-01 |
| Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib (NCT01928160) | Vanderbilt-Ingram Cancer Center | 2014-06-01 |
| Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer (NCT01784640) | Jonsson Comprehensive Cancer Center | 2014-01-31 |
| Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens (NCT01948141) | Roswell Park Cancer Institute | 2014-01-30 |
| Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer (NCT01824901) | ECOG-ACRIN Cancer Research Group | 2014-01-15 |
| Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients (NCT01999881) | University of Wisconsin, Madison | 2013-12-01 |
| Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection (NCT01249443) | AIDS Malignancy Consortium | 2013-11-01 |
| Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation (NCT02017925) | Ohio State University Comprehensive Cancer Center | 2013-10-01 |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers (NCT01935336) | University of Colorado, Denver | 2013-09-24 |
| Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer (NCT01839955) | Neelesh Sharma MD PhD | 2013-09-01 |
| INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer (NCT01911507) | University of California, Davis | 2013-08-27 |
| Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cancer (NCT02126527) | Mayo Clinic | 2013-08-01 |
| PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer (NCT01723800) | City of Hope Medical Center | 2013-07-01 |
| Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer (NCT01781741) | Roswell Park Cancer Institute | 2013-03-06 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers (NCT01729689) | Stanford University | 2012-11-01 |
| Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer (NCT01707823) | Vanderbilt-Ingram Cancer Center | 2012-10-01 |
| IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors (NCT01746810) | New Mexico Cancer Research Alliance | 2012-07-01 |
| Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II (NCT01649947) | Rutgers, The State University of New Jersey | 2011-12-23 |
| Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT01411098) | University of Washington | 2011-10-01 |
| Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer (NCT01383668) | Mayo Clinic | 2011-06-01 |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT01345851) | Jonsson Comprehensive Cancer Center | 2011-03-23 |
| RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy (NCT01193868) | National Cancer Institute (NCI) | 2010-09-01 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258) | University of Southern California | 2010-06-01 |
| Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer (NCT00976677) | National Cancer Institute (NCI) | 2010-01-01 |
| Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer (NCT01026467) | Wake Forest University Health Sciences | 2010-01-01 |
| Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC (NCT00769600) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-11-01 |
| Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00778167) | National Cancer Institute (NCI) | 2008-10-01 |
| APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer (NCT00652340) | Tragara Pharmaceuticals, Inc. | 2008-04-01 |
| AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy (NCT00638937) | National Cancer Institute (NCI) | 2008-02-01 |
| A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer (NCT02889666) | Shanghai Jiao Tong University School of Medicine | 2008-01-01 |
| Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NCT00499655) | City of Hope Medical Center | 2007-11-01 |
| Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT01557959) | Wake Forest University Health Sciences | 2007-07-01 |
| Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NCT00481078) | National Cancer Institute (NCI) | 2007-05-01 |
| Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NCT00459342) | National Cancer Institute (NCI) | 2007-03-01 |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384) | National Cancer Institute (NCI) | 2007-01-01 |
| E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00400829) | National Cancer Institute (NCI) | 2006-11-01 |
| AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer (NCT00410904) | National Cancer Institute (NCI) | 2006-10-01 |
| S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00368992) | National Cancer Institute (NCI) | 2006-08-01 |
| AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer (NCT00245063) | National Cancer Institute (NCI) | 2006-03-01 |
| Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00408460) | University of Washington | 2006-02-01 |
| Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00118183) | National Cancer Institute (NCI) | 2005-07-01 |
| Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer (NCT00118144) | National Cancer Institute (NCI) | 2005-06-01 |
| Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NCT00138203) | National Cancer Institute (NCI) | 2005-06-01 |
| Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer (NCT00101348) | National Cancer Institute (NCI) | 2005-01-01 |
| Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors (NCT00655655) | Mayo Clinic | 2004-12-01 |
| Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00098540) | National Cancer Institute (NCI) | 2004-12-01 |
| Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NCT00085280) | National Cancer Institute (NCI) | 2004-09-01 |
| Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer (NCT00093756) | National Cancer Institute (NCI) | 2004-09-01 |
| S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer (NCT00087412) | National Cancer Institute (NCI) | 2004-09-01 |
| A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer (NCT00077350) | National Cancer Institute (NCI) | 2004-07-01 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191) | National Cancer Institute (NCI) | 2004-05-01 |
| Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer (NCT00084981) | National Cancer Institute (NCI) | 2004-04-01 |
| CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer (NCT00079235) | National Cancer Institute (NCI) | 2004-02-01 |
| Photodynamic Therapy in Treating Patients With Lung Cancer (NCT01668823) | Roswell Park Cancer Institute | 2004-02-01 |
| Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer (NCT00075751) | National Cancer Institute (NCI) | 2004-01-01 |
| Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer (NCT00062101) | National Cancer Institute (NCI) | 2004-01-01 |
| Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00088959) | National Cancer Institute (NCI) | 2003-12-01 |
| Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer (NCT00068497) | National Cancer Institute (NCI) | 2003-08-01 |
| Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer (NCT00066768) | National Cancer Institute (NCI) | 2003-07-01 |
| Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine (NCT00228358) | University of Washington | 2003-06-01 |
| Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck (NCT00063895) | National Cancer Institute (NCI) | 2003-04-01 |
| Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer (NCT00052338) | National Cancer Institute (NCI) | 2002-09-01 |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer (NCT00021060) | National Cancer Institute (NCI) | 2002-08-01 |
| Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT00040768) | National Cancer Institute (NCI) | 2002-04-01 |
| Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer (NCT00039091) | National Cancer Institute (NCI) | 2002-03-01 |
| Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00029003) | National Cancer Institute (NCI) | 2001-12-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors (NCT00028535) | National Cancer Institute (NCI) | 2001-11-01 |
| Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer (NCT00006929) | National Cancer Institute (NCI) | 2000-09-01 |
| FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer (NCT00020202) | National Cancer Institute (NCI) | 2000-06-01 |
| Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 (NCT00004883) | National Cancer Institute (NCI) | 2000-02-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |